238 related articles for article (PubMed ID: 22711534)
1. Interleukin 6 signaling regulates promyelocytic leukemia protein gene expression in human normal and cancer cells.
Hubackova S; Krejcikova K; Bartek J; Hodny Z
J Biol Chem; 2012 Aug; 287(32):26702-14. PubMed ID: 22711534
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the PML tumor suppressor in drug-induced senescence of human normal and cancer cells by JAK/STAT-mediated signaling.
Hubackova S; Novakova Z; Krejcikova K; Kosar M; Dobrovolna J; Duskova P; Hanzlikova H; Vancurova M; Barath P; Bartek J; Hodny Z
Cell Cycle; 2010 Aug; 9(15):3085-99. PubMed ID: 20699642
[TBL] [Abstract][Full Text] [Related]
3. NEMO, a Transcriptional Target of Estrogen and Progesterone, Is Linked to Tumor Suppressor PML in Breast Cancer.
Elsarraj HS; Valdez KE; Hong Y; Grimm SL; Ricci LR; Fan F; Tawfik O; May L; Cusick T; Inciardi M; Redick M; Gatewood J; Winblad O; Hilsenbeck S; Edwards DP; Hagan CR; Godwin AK; Fabian C; Behbod F
Cancer Res; 2017 Jul; 77(14):3802-3813. PubMed ID: 28515148
[TBL] [Abstract][Full Text] [Related]
4. The helicase HAGE prevents interferon-α-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1.
Mathieu MG; Miles AK; Ahmad M; Buczek ME; Pockley AG; Rees RC; Regad T
Cell Death Dis; 2014 Feb; 5(2):e1061. PubMed ID: 24525737
[TBL] [Abstract][Full Text] [Related]
5. PML suppresses IL-6-induced STAT3 activation by interfering with STAT3 and HDAC3 interaction.
Kato M; Muromoto R; Togi S; Iwakami M; Kitai Y; Kon S; Oritani K; Matsuda T
Biochem Biophys Res Commun; 2015 May; 461(2):366-71. PubMed ID: 25892518
[TBL] [Abstract][Full Text] [Related]
6. Direct transcriptional activation of promyelocytic leukemia protein by IFN regulatory factor 3 induces the p53-dependent growth inhibition of cancer cells.
Kim TK; Lee JS; Oh SY; Jin X; Choi YJ; Lee TH; Lee Eh; Choi YK; You S; Chung YG; Lee JB; DePinho RA; Chin L; Kim H
Cancer Res; 2007 Dec; 67(23):11133-40. PubMed ID: 18056437
[TBL] [Abstract][Full Text] [Related]
7. PML promotes senescence via JAK/STAT signaling.
Krämer A
Cell Cycle; 2010 Aug; 9(15):2931. PubMed ID: 20703079
[No Abstract] [Full Text] [Related]
8. Critical role of presenilin-dependent γ-secretase activity in DNA damage-induced promyelocytic leukemia protein expression and apoptosis.
Song H; Boo JH; Kim KH; Kim C; Kim YE; Ahn JH; Jeon GS; Ryu H; Kang DE; Mook-Jung I
Cell Death Differ; 2013 Apr; 20(4):639-48. PubMed ID: 23306558
[TBL] [Abstract][Full Text] [Related]
9. PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia.
Boddy MN; Howe K; Etkin LD; Solomon E; Freemont PS
Oncogene; 1996 Sep; 13(5):971-82. PubMed ID: 8806687
[TBL] [Abstract][Full Text] [Related]
10. Loss of the promyelocytic leukemia protein in gastric cancer: implications for IP-10 expression and tumor-infiltrating lymphocytes.
Kim HJ; Song DE; Lim SY; Lee SH; Kang JL; Lee SJ; Benveniste EN; Choi YH
PLoS One; 2011; 6(10):e26264. PubMed ID: 22022583
[TBL] [Abstract][Full Text] [Related]
11. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E
Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078
[TBL] [Abstract][Full Text] [Related]
12. Promyelocytic leukemia protein (PML) regulates endothelial cell network formation and migration in response to tumor necrosis factor α (TNFα) and interferon α (IFNα).
Cheng X; Liu Y; Chu H; Kao HY
J Biol Chem; 2012 Jul; 287(28):23356-67. PubMed ID: 22589541
[TBL] [Abstract][Full Text] [Related]
13. Deacetylation of the tumor suppressor protein PML regulates hydrogen peroxide-induced cell death.
Guan D; Lim JH; Peng L; Liu Y; Lam M; Seto E; Kao HY
Cell Death Dis; 2014 Jul; 5(7):e1340. PubMed ID: 25032863
[TBL] [Abstract][Full Text] [Related]
14. Translation-dependent mechanisms lead to PML upregulation and mediate oncogenic K-RAS-induced cellular senescence.
Scaglioni PP; Rabellino A; Yung TM; Bernardi R; Choi S; Konstantinidou G; Nardella C; Cheng K; Pandolfi PP
EMBO Mol Med; 2012 Jul; 4(7):594-602. PubMed ID: 22359342
[TBL] [Abstract][Full Text] [Related]
15. Cytokine expression and signaling in drug-induced cellular senescence.
Novakova Z; Hubackova S; Kosar M; Janderova-Rossmeislova L; Dobrovolna J; Vasicova P; Vancurova M; Horejsi Z; Hozak P; Bartek J; Hodny Z
Oncogene; 2010 Jan; 29(2):273-84. PubMed ID: 19802007
[TBL] [Abstract][Full Text] [Related]
16. Opposing effects of PML and PML/RAR alpha on STAT3 activity.
Kawasaki A; Matsumura I; Kataoka Y; Takigawa E; Nakajima K; Kanakura Y
Blood; 2003 May; 101(9):3668-73. PubMed ID: 12506013
[TBL] [Abstract][Full Text] [Related]
17. Selective activation of NFAT by promyelocytic leukemia protein.
Lo YH; Wu CC; Shih HM; Lai MZ
Oncogene; 2008 Jun; 27(27):3821-30. PubMed ID: 18246125
[TBL] [Abstract][Full Text] [Related]
18. EVI1 abrogates interferon-alpha response by selectively blocking PML induction.
Buonamici S; Li D; Mikhail FM; Sassano A; Platanias LC; Colamonici O; Anastasi J; Nucifora G
J Biol Chem; 2005 Jan; 280(1):428-36. PubMed ID: 15519999
[TBL] [Abstract][Full Text] [Related]
19. Promyelocytic Leukemia Protein Isoform II Promotes Transcription Factor Recruitment To Activate Interferon Beta and Interferon-Responsive Gene Expression.
Chen Y; Wright J; Meng X; Leppard KN
Mol Cell Biol; 2015 May; 35(10):1660-72. PubMed ID: 25733689
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of PML by mitogen-activated protein kinases plays a key role in arsenic trioxide-mediated apoptosis.
Hayakawa F; Privalsky ML
Cancer Cell; 2004 Apr; 5(4):389-401. PubMed ID: 15093545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]